Literature DB >> 3924318

Hypophosphataemic osteomalacia associated with prostatic carcinoma.

P Murphy, G Wright, G S Rai.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924318      PMCID: PMC1416063          DOI: 10.1136/bmj.290.6486.1945

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Hypophosphatemic osteomalacia associated with "nonendocrine" tumors.

Authors:  R M Salassa; J Jowsey; C D Arnaud
Journal:  N Engl J Med       Date:  1970-07-09       Impact factor: 91.245

2.  Nomogram for derivation of renal threshold phosphate concentration.

Authors:  R J Walton; O L Bijvoet
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

3.  Osteomalacia and carcinoma of prostate with major redistribution of skeletal calcium.

Authors:  D J Hosking; M J Chamberlain; W R Shortland-Webb
Journal:  Br J Radiol       Date:  1975-06       Impact factor: 3.039

4.  Hypophosphatemic osteomalacia: association with prostatic carcinoma.

Authors:  K W Lyles; W R Berry; M Haussler; J M Harrelson; M K Drezner
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391

5.  Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.

Authors:  D L Citrin; P Elson; M S Kies; R Lind
Journal:  Am J Med       Date:  1984-05       Impact factor: 4.965

  5 in total
  3 in total

1.  Skeletal effects of carcinoma of the breast and prostate.

Authors:  R C Percival
Journal:  Ann R Coll Surg Engl       Date:  1986-09       Impact factor: 1.891

2.  Metastatic prostate cancer presenting as tumour-induced osteomalacia.

Authors:  Awo Akosua K Layman; Shivam Joshi; Sanjeev Shah
Journal:  BMJ Case Rep       Date:  2019-07-16

Review 3.  Molecular biology of hypophosphataemic rickets and oncogenic osteomalacia.

Authors:  P S Rowe
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.